Dr. Atul Gawande, CEO of Haven, stepped down from the high-profile healthcare venture to focus on Covid-19. He will become chairman of the company while it searches for a new CEO.
Stoddard told CNBC that the frequent travel between Haven's Boston headquarters and his home in Philadelphia was taking a toll on his personal and family life
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
The Amazon-Berkshire-J.P. Morgan healthcare venture launched last year and headed up by Atul Gawande has a website and finally a name: Haven.
According to ABJ COO Jack Stoddard, the initial focus of the collaborative is gathering data and researching the levers that drive costs and prices in healthcare.
A selection of the biggest payer stories in 2018, ranging from Amazon's healthcare incursion to Medicare Advantage's continued growth.
During an event Rock Health Summit in San Francisco, the always quotable Cosgrove shared his thoughts on topics ranging from the V.A. to Theranos to EMRs to where he believed big tech firms can hope to change healthcare.
The yet-unnamed Amazon-Berkshire Hathaway-J.P. Morgan healthcare venture has selected Jack Stoddard, who previously was Comcast's general manager of digital health, as its chief operating officer.
Gawande said the health system is moving “from individual delivery of stuff … to team delivery of outcomes. And that’s a radically different place.” He wants to help make that transition more effective.
Effective July 9, surgeon and author Atul Gawande, who has been outspoken about healthcare costs and quality, will take over as CEO of the new initiative.
At West Health's Healthcare Costs Innovation Summit on February 21, panelists and presenters discussed value-based care, the cost of unnecessary treatment and how America's broken political system is impacting healthcare.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Called United States of Care, the advocacy initiative's goal is to ensure all Americans have access to affordable care. The group is non-partisan and seeks to "put healthcare over politics."
Pointing out the problems is the easy part. Action is the next big step.
Dr. Atul Gawande has done it again. Writing in the New Yorker, Gawande, a general surgeon at Brigham and Women’s Hospital in Boston, author and MacArthur Foundation “genius grant” recipient, painstakingly explains the “epidemic of unnecessary care” that bears much of the blame for the country’s runaway healthcare costs and preventable deaths. Gawande also looked […]
The ever-prolific Atul Gawande chatted it up last night with Jon Stewart on the Daily Show, promoting his latest book, “Being Mortal.” The two discussed end-of-life care – and how patients and physicians should temper their pursuit of “doing whatever they can” in favor of living out life in a more meaningful way. For instance, Gawande noted that at […]
A country physician-turned-innovator has created a device to help physicians resuscitate the more than 10 percent* of babies who are born not breathing. Neonatal is a growing area of global concern and has a lot of room for innovation. Already, nonprofit Helping Babies Breathe, an American Academy of Pediatrics program, educates birth attendants on how to […]
